After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed Natera Announces Next Phase of CareDx Patent Infringement Litigation Seeking Royalty For All Ongoing And Future AlloSure Tests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NASDAQ-listed company operates within the Diagnostics & Research industry segment, falling under the Healthcare sector. The current market capitalization of Natera Inc is $9.15B. A total of 2.31 million shares were traded on the day, compared to an average of 1.38M shares.
Insider Activity
Insider trades can also provide insight into a stock’s future direction. During the recent three months, NTRA has seen 0 BUY and 1 SELL insider trades, representing the acquisition of 0 and the disposition of 644,000 shares. Over the last 12 months, there were 69 BUYs and 87 SELLs from insiders. Insiders purchased 126,636 shares during that period but sold 837,448.
In the most recent transaction, ROSENMAN HERM sold 93,901 shares of NTRA for 69.37 per share on Feb 16. After the transaction, the Director now owns 61,685 company shares. In a previous transaction on Feb 07, Sheena Jonathan sold 5,000 shares at 70.10 per share. NTRA shares that CO-FOUNDER owns now total 473,585.
Among the insiders who sold shares, Sheena Jonathan disposed of 1,000 shares on Feb 07 at a per-share price of $70.10. This resulted in the CO-FOUNDER holding 17,655 shares of NTRA after the transaction. In another insider transaction, Brophy Michael Burkes sold 34,029 shares at $70.03 per share on Feb 06. Company shares held by the CHIEF FINANCIAL OFFICER now total 70,646.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for NTRA in the last 3 months, the mean price target is $77.59 with high estimates of $117.00 and low estimates of $37.00. In terms of 52-week highs and lows, NTRA has a high of $74.79 and a low of $36.90.
As of this writing, NTRA has an earnings estimate of -$0.73 per share for the current quarter. EPS was calculated based on a consensus of 17 estimates, with a high estimate of -$0.56 per share and a lower estimate of -$0.87. The company reported an EPS of -$0.97 in the last quarter, which was 11.00% higher than expectations of -$1.09.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. NTRA’s latest balance sheet shows that the firm has $914.28M in Cash & Short Term Investments as of fiscal 2021. There were $397.23M in debt and $218.96M in liabilities at the time. Its Book Value Per Share was $6.59, while its Total Shareholder’s Equity was $653.30M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NTRA is Buy with a score of 4.71.
